In a bold move to meet the growing demand for advanced materials in the healthcare sector, Arkema and ALBIS have announced a strategic partnership for the distribution of Arkema’s high-performance medical-grade polymers. Effective immediately, ALBIS will distribute a comprehensive range of Arkema’s medical-grade materials, including Pebax® MED thermoplastic elastomers, Rilsan MED polyamide 11, Rilsamid MED polyamide 12, Rilsan  MED Clear transparent polyamide, and Kynar MED PVDF.

This partnership marks a significant expansion of ALBIS’s product offerings, as it adds Arkema’s renowned polymers to its portfolio. ALBIS, already a leading distributor of engineering and high-performance plastics, will distribute these advanced materials across Europe, North Africa, and the Middle East, a move designed to strengthen their position in the global healthcare market.

Arkema’s medical-grade materials are designed to meet the strictest biocompatibility standards, including compliance with USP Class VI and ISO 10993 regulations. These polymers are engineered for use in critical applications, from minimally invasive medical devices to high-performance medical tubing and equipment. Known for their chemical resistance, flexibility, and durability, Arkema’s materials are ideal for manufacturers looking for robust, reliable solutions in the healthcare field.

David Dupont, Vice President of Specialty Polyamides at Arkema, expressed enthusiasm for the partnership, stating, “With ALBIS, we are making our advanced materials even more accessible to meet the increasing demand for innovation in the healthcare sector. ALBIS’s deep technical expertise and excellent customer service make them an ideal partner for us as we continue to expand our presence in this vital market.”

For ALBIS, the inclusion of Arkema’s high-performance medical-grade materials adds significant value to its already robust healthcare portfolio. Mike Freudenstein, Senior Director of Marketing for Healthcare & Industry Management at ALBIS, noted, “We are very pleased to add Arkema’s renowned brands to our healthcare offerings. These advanced materials are a perfect complement to our existing range, and now, we can provide an even more comprehensive set of solutions to our healthcare customers, including bio-based options.”

This partnership is expected to drive growth in the medical and healthcare sector, where the demand for reliable, innovative, and biocompatible materials is on the rise. With both companies bringing their respective strengths to the table, this collaboration is set to redefine the distribution of high-performance polymers, offering critical solutions for the healthcare industry’s most demanding applications.

The collaboration underscores Arkema's and ALBIS’s commitment to supporting innovation and sustainability in the medical field, positioning them as key players in the next generation of medical-grade materials.